{"id":"NCT01857206","sponsor":"Novartis Vaccines","briefTitle":"Safety of Two Trivalent Influenza Vaccines Evaluated in Children and Adolescents 4 to 17 Years of Age","officialTitle":"A Phase III, Observer Blind, Randomized, Controlled, Multicenter Study to Evaluate the Safety of a Trivalent Subunit Influenza Vaccine Produced Either in Mammalian Cell Culture or in Embryonated Chicken Eggs (Fluvirin®), in Healthy Children and Adolescents 4 to 17 Years of Age.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-05","primaryCompletion":"2014-06","completion":"2014-06","firstPosted":"2013-05-20","resultsPosted":"2014-11-03","lastUpdate":"2014-12-05"},"enrollment":2055,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"PREVENTION"},"conditions":["Influenza","Fever"],"interventions":[{"type":"BIOLOGICAL","name":"Mammalian cell based flu vaccine","otherNames":[]},{"type":"BIOLOGICAL","name":"Egg based flu vaccine","otherNames":[]}],"arms":[{"label":"TIVc","type":"EXPERIMENTAL"},{"label":"TIVf","type":"ACTIVE_COMPARATOR"}],"summary":"Evaluate safety and tolerability of TIVa or TIVb vaccine in healthy children and adolescents 4 to 17 years of age.","primaryOutcome":{"measure":"Number Of Subjects Reporting Solicited Local and Systemic Adverse Events and Other Indicators Of Reactogenicity After Any Vaccination.","timeFrame":"Day 1 to Day 7 after any vaccination","effectByArm":[{"arm":"TIVc (≥4 to ≤8 Years)","deltaMin":422,"sd":null},{"arm":"TIVf (≥4 to ≤8 Years)","deltaMin":202,"sd":null},{"arm":"TIVc (≥9 to ≤17 Years)","deltaMin":370,"sd":null},{"arm":"TIVf (≥9 to ≤17 Years)","deltaMin":160,"sd":null}],"pValues":[]},"eligibility":{"minAge":"4 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":3},"locations":{"siteCount":34,"countries":["United States","Australia","New Zealand","Philippines","Thailand"]},"refs":{"pmids":["26643931"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":17,"n":688},"commonTop":["INJECTION SITE PAIN","INJECTION SITE ERYTHEMA","HEADACHE","MYALGIA","MALAISE"]}}